-
EP3518913
European procedure
- EP About this file
- EP Legal status
- EP Federated register
- EP Event history
- EP Citations
- EP Patent family
- EP All documents
Extract from the Register of European Patents
EP About this file: EP3518913
| EP3518913 - METHODS FOR TREATING OCULAR DISEASES [Right-click to bookmark this link] | Status | Examination is in progress Status updated on 22.12.2023 Database last updated on 19.10.2024 | |
| Former | Request for examination was made Status updated on 05.07.2019 | ||
| Former | The international publication has been made Status updated on 07.04.2018 | Most recent event Tooltip | 13.07.2024 | New entry: Renewal fee paid | Applicant(s) | For all designated states Novelwise Pharmaceutical Corporation 17F., No. 3, Yuanqu St. Nangang Dist. Taipei City 115603, Taiwan / TW | [2024/06] |
| Former [2019/32] | For all designated states NatureWise Biotech & Medicals Corporation 6F, No. 36, Section 3 Bade Road Songshan District Taipei City 105 / TW | Inventor(s) | 01 /
CHIOU, George Chung-Yih 6F. No.36,Sec. 3, Bade Rd. Songshan Dist. Taipei City 105 / TW | 02 /
CHEN, Chia-Nan 6F. No.75-3 Tianmu E. Rd. Shilin Dist. Taipei City 111 / TW | [2019/36] |
| Former [2019/32] | 01 /
CHIOU, George Chung-Yih 6F. No.75-3 Tianmu E. Rd. Shilin Dist. Taipei City 111 / TW | ||
| 02 /
CHEN, Chia-Nan 6F. No.75-3 Tianmu E. Rd. Shilin Dist. Taipei City 111 / TW | Representative(s) | Straus, Alexander, et al 2K Patent- und Rechtsanwälte Bajuwarenring 14 82041 Oberhaching / DE | [N/P] |
| Former [2019/32] | Becker Kurig Straus Patentanwälte Bavariastrasse 7 80336 München / DE | Application number, filing date | 17854993.7 | 29.09.2017 | [2019/32] | WO2017CN104345 | Priority number, date | US201662401725P | 29.09.2016 Original published format: US 201662401725 P | [2019/32] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2018059543 | Date: | 05.04.2018 | Language: | EN | [2018/14] | Type: | A1 Application with search report | No.: | EP3518913 | Date: | 07.08.2019 | Language: | EN | The application published by WIPO in one of the EPO official languages on 05.04.2018 takes the place of the publication of the European patent application. | [2019/32] | Search report(s) | International search report - published on: | CN | 05.04.2018 | (Supplementary) European search report - dispatched on: | EP | 28.04.2020 | Classification | IPC: | A61K31/165, A61P27/02, A61P27/06 | [2019/32] | CPC: |
A61K9/0048 (EP,KR,US);
A61K31/165 (KR);
A61K31/185 (US);
A61K31/16 (EP,US);
A61K9/0014 (US);
A61K9/0053 (EP,KR,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2019/32] | Title | German: | VERFAHREN ZUR BEHANDLUNG VON AUGENERKRANKUNGEN | [2019/32] | English: | METHODS FOR TREATING OCULAR DISEASES | [2019/32] | French: | MÉTHODES DE TRAITEMENT DE MALADIES OCULAIRES | [2019/32] | Entry into regional phase | 13.03.2019 | National basic fee paid | 13.03.2019 | Search fee paid | 13.03.2019 | Designation fee(s) paid | 13.03.2019 | Examination fee paid | Examination procedure | 13.03.2019 | Examination requested [2019/32] | 25.11.2020 | Amendment by applicant (claims and/or description) | 21.12.2023 | Despatch of a communication from the examining division (Time limit: M04) | 22.04.2024 | Reply to a communication from the examining division | Fees paid | Renewal fee | 31.07.2019 | Renewal fee patent year 03 | 30.09.2020 | Renewal fee patent year 04 | 30.07.2021 | Renewal fee patent year 05 | 29.08.2022 | Renewal fee patent year 06 | 28.08.2023 | Renewal fee patent year 07 | 12.07.2024 | Renewal fee patent year 08 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Documents cited: | Search | [A]EP2236503 (NATUREWISE BIOTECH & MEDICALS [TW]); | [A]EP2277387 (NATUREWISE BIOTECH & MEDICALS CORP [TW]); |